Second-generation tyrosine kinase inhibitors in the post-transplant period in patients with chronic myeloid leukemia or Philadelphia-positive acute lymphoblastic leukemia

MeSH terms

• Aged
• Aniline Compounds / therapeutic use
• Benzamides
• Dasatinib
• Female
• Humans
• Imatinib Mesylate
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
• Male
• Middle Aged
• Nitriles / therapeutic use
• Piperazines / therapeutic use
• Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
• Protein Kinase Inhibitors / therapeutic use*
• Protein-Tyrosine Kinases / antagonists & inhibitors*
• Pyrimidines / therapeutic use
• Quinolines / therapeutic use
• Stem Cell Transplantation
• Thiazoles / therapeutic use